118 transplantation. One of the goals of this investigation is to find the reasons why such non 119 optimal care persists and how it can be improved.
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Observations as the ones above can also be found in the international literature. For 122 instance, there is growing concern that access to transplantation is neither consistent nor 123 equitable [20] . From the United States and the United Kingdom, racial or ethnical [21, 22] 124 and age disparities [23] [24] [25] within the patient population are reported as prominent barriers in 125 access to kidney transplantation. Other potential barriers include lower socioeconomic status 126 and poor education leading to a lack of knowledge [26] .
127 Also in the Dutch renal care setting, patients with a migration background and older 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 insurers have yet to be investigated. More insight could help finding strategies to facilitating 187 better timing and a more equal access to optimal treatment.
188 Objectives 189 The aim of this project is to qualitatively explore factors that influence more optimal access 190 to kidney transplantation from the perspectives of different stakeholders in the Dutch setting, 191 using grounded theory as the qualitative research method. Hence, perspectives of multiple 192 stakeholders will be included, and therefore factors on different levels will be explored, Patients and most stakeholders were already involved in the study design. As the protocol 207 was a grant proposal of the Dutch Kidney Foundation, the protocol was also judged by the 208 patient reviewers. The study group is regularly advised by an advisory board which includes 209 representatives of most stakeholders groups involved: nephrologists, policy makers, patients 210 and representatives of the kidney patient association and others. This board helps for instance 211 in thinking about optimal logistical planning for the different groups to keep the research 212 burden for participants as low as possible. 214 The study population will be organized in seven stakeholder groups, namely patients 215 (predialysis, pre-and post-transplantation group), nephrology and transplantation nurses, 216 social workers, nephrologists, health insurers and policy makers.
217 Eligible patients are adults (>18 yrs old) who have whether 1) been transplanted preemptively 218 or non preemptively but underwent dialysis for less than one year before transplantation or 219 who have 2) a kidney function of eGFR<15ml/min and for whom initiation of dialysis can be 220 expected within less than three months. Additionally, family members and (potential) donors 221 of the kidney patients will be invited to take part in the patient focus groups.
222 The to be recruited professional groups will be nephrologists, and nephrology and 223 transplantation nurses as well as social workers, representatives of health insurances and 224 policy makers working in the field of kidney transplantation throughout the Netherlands.
225 Policy makers and health insurers will be representatives of national and regional institutions 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  p  e  e  r  r  e  v  i  e  w  o  n  l  y   9 241 During the course of the interviews, we will also consult earlier participants to identify 242 potential participants from the above mentioned stakeholder groups (snowball sampling).
243
The senior researchers know a number of the participants from their existing professional 244 network, but a prior acquaintance with the participants was neither an inclusion nor exclusion 245 criterion.
246 The prospective participants will receive a participant information letter with detailed 247 information about the study and its accomplishment including audio-recording and voluntary 248 participation as well as the informed consent form for signature. Participation is completely 249 voluntary: subjects can leave the study at any time for any reason if they wish to do so 250 without stating any reason and without any consequences for their medical treatment (for 251 patients) or current function (for professionals). If a participant is willing to participate, a 252 study interviewer will invite him or her by telephone or e-mail for the interview.
253 Our aim is to reduce logistical barriers for all participants as much as possible. Therefore, the 254 focus groups for patients will be held either in the hospital or in a remote location of choice, 255 i.e. a community center. For health care professionals, individual interviews will be held at or 256 close to their workplace. Focus group sessions will be held prior to or after regional 257 nephrology or transplantation meetings. Adjunct to this, if necessary, national congress 258 meetings will be used as a venue to conduct the focus groups among healthcare professionals.
259 For policy and health insurance representatives we will strive to conduct the focus groups at 260 their place of work. Researchers will try to match participants' wishes with the feasibility of 261 the study. In coordination with the participant an appointment and location for the interview 262 will be assigned. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 273 Three phases 274 The interviews will be conducted in three phases. In the first phase, we will try to gather as 275 much information as possible about factors that influence the access to transplantation 276 according to the stakeholder groups by proceeding individual or focus group interviews. In 277 this first phase focus groups will be organized separately for pre-dialysis and pre-or post-278 transplantation patients, nephrologists, nurses, social workers, policy makers and insurance 279 representatives. This homogeneity within the focus groups will ensure that participants are 280 able to raise issues for discussion. Too much heterogeneity will inhibit discussion, especially 281 when there are status distinctions between participants [42].
282 In the second phase, focus groups will be held with the same stakeholder groups as in the first 283 phase. In the beginning, stakeholders will be confronted with the outcomes of the first phase 284 from their own but also from the other stakeholder groups. The objective of this phase is to 285 let participants of each group reflect on the factors mentioned by their group but also by 286 stakeholders from the other groups, on what factors they think influence access to 287 transplantation. The expectation is that due to this iterative process, a more integrated model 288 can be generated of the factors that can influence access to transplantation, from different 289 perspectives. 290 291 In the third phase, focus group sessions will be held with the same respective stakeholder 292 groups from the previous two phases. Again, results from the previous phase will be 293 presented in the beginning. The main objective of these focus groups will be to generate 294 solutions for the integrated hindering or facilitating factors that emerged in the second phase.
295 Participants that already took part in one phase will be invited to return to another phase of 296 the study. New participants will also be welcome to further prevent dropout.
297 The three phases of this study will each encompass approximately one year. The first one or 298 two months of each year will be used to write down a detailed script for conducting the focus 299 groups. The last one or two months of each year will be used for transcribing and analyzing 300 the data. The remaining eight to ten months will be used for the most important part of this 301 study, namely recruiting participants for the interviews and conducting the individual 306 The individual interviews and the focus group interviews will be conducted by a moderator.
307 These will be the junior researcher in Medical Psychology, a transplantation coordinator, or a 308 senior researcher in Medical Psychology, with assistance of one of the other colleagues who 309 will take back-up paper and pencil notes and will monitor the discussed topics. All 310 researchers have knowledge of qualitative methods based on previous research projects and 311 training. The interviews will be audio-recorded after signed informed consent of the 312 participant. If a participant does not master the Dutch language, the use of a translated 313 questionnaire and an interpreter for interviews will be considered.
314 The interviews will last about 45 minutes to 1.5 hours for the individual interviews and about 315 2 to 3 hours for focus groups, respectively. Participants will be asked what their attitudes, 316 opinions, preferences and beliefs are regarding access to transplantation. The interviews will 317 cover the topics clinical, psychological, social, ethical, economic, and policy factors 318 influencing access to transplantation. The moderators will make use of an interview guide to 319 monitor the topics discussed and to be able to offer prompts or sub-questions to a topic in 320 case a participant does not raise a topic by himself or cannot come up spontaneously with any 321 thoughts on one topic.
322 During the focus group sessions, the moderator will also use a flipchart to make notes for the 323 group. The mediator will keep the discussion going and make sure that every participant gets 324 the chance to contribute. At the end of a focus group session, the mediator will hold a 325 debriefing, that is a summary of the raised issues. Finally, the participants will be asked to fill 326 in a short questionnaire about their sociodemographic characteristics, their type of therapy 327 (for patients) or their current function (for professionals). If necessary, the questionnaire is 328 offered in other languages than Dutch.
329 Both types of interviews will be transcribed verbatim and the names of the participants will 330 be replaced with identification codes to assure anonymity. If necessary, transcriptions will be 331 translated into the Dutch language. We will not return the transcripts to participants for 
Data analysis
336 337 Data from the interviews will be analyzed according to the principles of grounded theory 338 [44] . Using this inductive approach, a model or theory will be developed on the basis of the 339 qualitative data generated. This approach is chosen as some perspectives of stakeholder 340 groups have never been studied and because an integrated model based on the perspectives of 341 the multiple stakeholders has never been formulated.
342 Two researchers will read through the interview transcripts independently and data-driven 343 codes will be assigned based on words and phrases [45] . This process goes on until the two 344 researchers separately worked through the whole transcript. The steps of open, axial and 345 selective coding will be taken. Therefore, codes will be combined in order to generate a 346 covering category. The two researchers then jointly cluster the derived categories into 347 themes. Thereby, they identify the underlying uniformities of the categories and further 348 sharpen the conceptual structure of each theme. During analysis, it is also important to 349 measure the extensiveness (frequency, intensity and specificity) in which a topic is discussed. Sample size calculation 367 We did an effort to calculate the sample size on the basis of focus groups only. The focus 368 groups will be organized homogenous, thus, subdivided in the seven study groups. Four to six 369 focus groups will be held per study group [40] or until data-saturation has been achieved [45,
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Equal access to transplantation can be defined in different ways. In this study we will 97 regard equality in terms of sociodemographic aspects such as migration background and age, 98 medical aspects such as comorbidity or HLA and blood type matching and timely aspects 99 such as the work-up process of patients referred to transplantation screening or facilitating the 100 preemptive trajectory.
101
The idea of unequal access to transplantation can be supported by the large prevalence of 112 Another indication for inequality in access to transplantation can be, that there might be a 113 group of patients that has been on dialysis for years, without even been screened or discussed 114 for transplantation (with the transplantations centers). For the group of patients that has been 115 on dialysis for a short period, a part might have missed the opportunity of preemptive 116 transplantation. One of the goals of this investigation is to find the reasons why such non 117 optimal care persists and how it can be improved. Observations as the ones above can also be found in the international literature. For 120 instance, there is growing concern that access to transplantation is neither consistent nor insurers have yet to be investigated. More insight could help finding strategies to facilitating 185 better timing and a more equal access to optimal treatment. 186 Objectives 187 The aim of this project is to qualitatively explore factors that influence more optimal access to 188 kidney transplantation from the perspectives of different stakeholders in the Dutch setting, 189 using grounded theory as the qualitative research method. Hence, perspectives of multiple 190 stakeholders will be included, and therefore factors on different levels will be explored, namely 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 211 The study population will be organized in seven stakeholder groups, namely patients 212 (predialysis, pre-and post-transplantation group), nephrology and transplantation nurses, social 213 workers, nephrologists, health insurers and policy makers.
214 Eligible patients are adults (>18 yrs old) who have whether 1) been transplanted preemptively 215 or non preemptively but underwent dialysis for less than one year before transplantation or who 216 have 2) a kidney function of eGFR<15ml/min and for whom initiation of dialysis can be 217 expected within less than three months. Additionally, family members and (potential) donors 218 of the kidney patients will be invited to take part in the patient focus groups.
219 The to be recruited professional groups will be nephrologists, and nephrology and 220 transplantation nurses as well as social workers, representatives of health insurances and policy 221 makers working in the field of kidney transplantation throughout the Netherlands. Policy 222 makers and health insurers will be representatives of national and regional institutions like 231 Professionals will be recruited via the professional federations and institutions mentioned 232 above or through different treatment centers such as the university transplantation centers, the 233 regional hospitals and dialysis centers from different regions. The Dutch Federations of the 234 distinct professional groups will be approached to assist us in reaching out to these 235 professionals. Policy employees or governors from hospitals or governmental institutions, 236 employees, representatives or delegates from health insurance companies will be identified 237 through Dutch Federations and nephrologists. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 238 During the course of the interviews, we will also consult earlier participants to identify potential 239 participants from the above mentioned stakeholder groups (snowball sampling).
240 The senior researchers know a number of the participants from their existing professional 241 network, but a prior acquaintance with the participants was neither an inclusion nor exclusion 242 criterion.
243 The prospective participants will receive a participant information letter with detailed 244 information about the study and its accomplishment including audio-recording and voluntary 245 participation as well as the informed consent form for signature. Participation is completely 246 voluntary: subjects can leave the study at any time for any reason if they wish to do so without 247 stating any reason and without any consequences for their medical treatment (for patients) or 248 current function (for professionals). If a participant is willing to participate, a study interviewer 249 will invite him or her by telephone or e-mail for the interview.
250 Our aim is to reduce logistical barriers for all participants as much as possible. Therefore, the 251 focus groups for patients will be held either in the hospital or in a remote location of choice, 252 i.e. a community center. For health care professionals, individual interviews will be held at or 253 close to their workplace. Focus group sessions will be held prior to or after regional nephrology 254 or transplantation meetings. Adjunct to this, if necessary, national congress meetings will be 255 used as a venue to conduct the focus groups among healthcare professionals. For policy and 256 health insurance representatives we will strive to conduct the focus groups at their place of 257 work. Researchers will try to match participants' wishes with the feasibility of the study. In 258 coordination with the participant an appointment and location for the interview will be 259 assigned. It could be that different settings (location, number and type of co-participants, time 260 of the year, etc.) might provoke different responses. We aim at minimizing such variations and 261 maximizing the input that participants can and are willing to give. Therefore, the interviewers 262 are trained and consequently (monthly) supervised to stimulate the responses/discussions in 263 such a way that maximal saturation can be reached (i.e. making sure that the participant can 264 maximally elaborate on all presented/emerging topics).
265 Design & procedure 266 Participants will be invited to taking part in whether an individual interview or a focus group 267 interview. The choice of using both group and individual interviews makes it possible to profit 268 from the advantages of both methods: focus group interviews facilitate a broader exploration, 275 Three phases 276 The interviews will be conducted in three phases. In the first phase, we will try to gather as 277 much information as possible about factors that influence the access to transplantation 278 according to the stakeholder groups by proceeding individual or focus group interviews. In this 279 first phase focus groups will be organized separately for pre-dialysis and pre-or post-280 transplantation patients, nephrologists, nurses, social workers, policy makers and insurance 281 representatives. This homogeneity within the focus groups will ensure that participants are able 282 to raise issues for discussion. Too much heterogeneity will inhibit discussion, especially when 283 there are status distinctions between participants [42].
284 In the second phase, focus groups will be held with the same stakeholder groups as in the first 285 phase. In the beginning, stakeholders will be confronted with the outcomes of the first phase 286 from their own but also from the other stakeholder groups. The objective of this phase is to 287 let participants of each group reflect on the factors mentioned by their group but also by 288 stakeholders from the other groups, on what factors they think influence access to 289 transplantation. The expectation is that due to this iterative process, a more integrated model 290 can be generated of the factors that can influence access to transplantation, from different 291 perspectives.
292 293 In the third phase, focus group sessions will be held with the same respective stakeholder 294 groups from the previous two phases. Again, results from the previous phase will be 295 presented in the beginning. The main objective of these focus groups will be to generate 296 solutions for the integrated hindering or facilitating factors that emerged in the second phase.
297 Participants that already took part in one phase will be invited to return to another phase of 298 the study. New participants will also be welcome to further prevent dropout.
299 The three phases of this study will each encompass approximately one year. The first one or 300 two months of each year will be used to write down a detailed script for conducting the focus 308 The individual interviews and the focus group interviews will be conducted by a moderator.
309 These will be the junior researcher in Medical Psychology, a transplantation coordinator, or a 310 senior researcher in Medical Psychology, with assistance of one of the other colleagues who 311 will take back-up paper and pencil notes and will monitor the discussed topics. All researchers 312 have knowledge of qualitative methods based on previous research projects and training. The 313 interviews will be audio-recorded after signed informed consent of the participant. If a 314 participant does not master the Dutch language, the use of a translated questionnaire and an 315 interpreter for interviews will be considered.
316 The interviews will last about 45 minutes to 1.5 hours for the individual interviews and about 317 2 to 3 hours for focus groups, respectively. Participants will be asked what their attitudes, 318 opinions, preferences and beliefs are regarding access to transplantation. The interviews will 319 cover the topics clinical, psychological, social, ethical, economic, and policy factors 320 influencing access to transplantation. The moderators will make use of an interview guide to 321 monitor the topics discussed and to be able to offer prompts or sub-questions to a topic in case 322 a participant does not raise a topic by himself or cannot come up spontaneously with any 323 thoughts on one topic.
324 During the focus group sessions, the moderator will also use a flipchart to make notes for the 325 group. The mediator will keep the discussion going and make sure that every participant gets 326 the chance to contribute. At the end of a focus group session, the mediator will hold a 327 debriefing, that is a summary of the raised issues. Finally, the participants will be asked to fill 328 in a short questionnaire about their sociodemographic characteristics, their type of therapy (for 329 patients) or their current function (for professionals). If necessary, the questionnaire is offered 330 in other languages than Dutch. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
